PGP and neoplasm: Multiple strategies to reverse P-gp-mediated MDR have been investigated, including designing inhibitors to block ATP-dependent P-gp activity to block efflux and recover drug accumulation, as well as exploring small molecules to reduce P-gp levels in MDR tumor cells [25–28].